116 related articles for article (PubMed ID: 6467199)
1. Effects of tamoxifen on estrogen-induced enhancement or inhibition of tumor growth in mouse Leydig cell tumor lines.
Sato B; Maeda Y; Nishizawa Y; Noma K; Kishimoto S; Matsumoto K
Cancer Res; 1984 Oct; 44(10):4386-91. PubMed ID: 6467199
[TBL] [Abstract][Full Text] [Related]
2. Effects of estrogen and tamoxifen on secretory glycoprotein synthesis in mouse Leydig cell tumor in vivo.
Nishizawa Y; Sato B; Kishimoto S; Matsumoto K
Anticancer Res; 1988; 8(4):557-62. PubMed ID: 3178148
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a unique nuclear estrogen-binding component in an estrogen-responsive mouse Leydig cell tumor.
Maeda Y; Sato B; Noma K; Kishimoto S; Koizumi K; Aono T; Matsumoto K
Cancer Res; 1983 Sep; 43(9):4091-7. PubMed ID: 6871850
[TBL] [Abstract][Full Text] [Related]
4. Biological and biochemical characterization of estrogen-dependent mouse Leydig cell tumors.
Sato B; Miyashita Y; Nishizawa Y; Noma K; Kishimoto S; Mori H; Matsumoto K
J Steroid Biochem; 1987; 27(1-3):421-9. PubMed ID: 3695489
[TBL] [Abstract][Full Text] [Related]
5. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
Miller MA; Lippman ME; Katzenellenbogen BS
Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
[TBL] [Abstract][Full Text] [Related]
6. Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse.
Gottardis MM; Robinson SP; Satyaswaroop PG; Jordan VC
Cancer Res; 1988 Feb; 48(4):812-5. PubMed ID: 3338079
[TBL] [Abstract][Full Text] [Related]
7. Dormancy versus extinction of mouse Leydig cell tumors following endocrine-induced regression.
Huseby RA
Cancer Res; 1983 Nov; 43(11):5365-78. PubMed ID: 6616470
[TBL] [Abstract][Full Text] [Related]
8. Autocrine regulation of cell proliferation by estradiol and hydroxytamoxifen of transformed mouse Leydig cells in serum-free culture.
Nishizawa Y; Sato B; Miyashita Y; Tsukada S; Hirose T; Kishimoto S; Matsumoto K
Endocrinology; 1988 Jan; 122(1):227-35. PubMed ID: 3275537
[TBL] [Abstract][Full Text] [Related]
9. Interactions of putative estrogens with the intracellular receptor complex in mouse Leydig cells: relationship to preneoplastic hyperplasia.
Juriansz RL; Huseby RA; Wilcox RB
Cancer Res; 1988 Jan; 48(1):14-8. PubMed ID: 3334987
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen regulation of ectocervical cell differentiation.
Macinga D; Jain V; Sizemore N; Gorodeski GI; Eckert RL; Rorke EA
J Soc Gynecol Investig; 1995; 2(6):754-61. PubMed ID: 9420886
[TBL] [Abstract][Full Text] [Related]
11. Stimulation by estrogen and progesterone of the in vivo growth of transformed murine Leydig cells only at the limited early phase of growth.
Yamamoto T; Li I; Uchida N; Nishizawa Y; Yamamoto R; Terada N; Taniguchi H; Matsumoto K; Sato B
Anticancer Res; 1992; 12(5):1339-45. PubMed ID: 1444190
[TBL] [Abstract][Full Text] [Related]
12. Apparent lack of immunogenicity of estrogen-induced testicular Leydig cell tumors in BALB/c mice.
Huseby RA; Page RH
Cancer Res; 1982 Nov; 42(11):4332-8. PubMed ID: 6751521
[TBL] [Abstract][Full Text] [Related]
13. Steroid receptor forms and their interaction with cytoplasmic modulators.
Sato B; Nishizawa Y; Maeda Y; Noma K; Honma T; Matsumoto K
J Steroid Biochem; 1983 Jul; 19(1A):315-21. PubMed ID: 6887866
[TBL] [Abstract][Full Text] [Related]
14. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen.
Chen J; Power KA; Mann J; Cheng A; Thompson LU
Exp Biol Med (Maywood); 2007 Sep; 232(8):1071-80. PubMed ID: 17720953
[TBL] [Abstract][Full Text] [Related]
15. Effect of androgen on proliferation of estrogen-responsive transformed mouse Leydig cells in serum-free culture.
Nishizawa Y; Sato B; Nishii K; Kishimoto S; Matsumoto K
Cancer Res; 1989 Mar; 49(6):1377-82. PubMed ID: 2924294
[TBL] [Abstract][Full Text] [Related]
16. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC
Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of hamster melanoma growth by estrogen.
Schleicher RL; Hitselberger MH; Beattie CW
Cancer Res; 1987 Jan; 47(2):453-9. PubMed ID: 3098410
[TBL] [Abstract][Full Text] [Related]
18. Growth-stimulative effect of estrogen on androgen-dependent Shionogi carcinoma 115.
Noguchi S; Kitamura Y; Uchida N; Yamaguchi K; Sato B; Matsumoto K
Cancer Res; 1984 Dec; 44(12 Pt 1):5644-9. PubMed ID: 6498825
[TBL] [Abstract][Full Text] [Related]
19. Antiestrogen inhibition of prolactin-induced growth of the Nb2 rat lymphoma cell line.
Biswas R; Vonderhaar BK
Cancer Res; 1989 Nov; 49(22):6295-9. PubMed ID: 2804977
[TBL] [Abstract][Full Text] [Related]
20. Embryonal mass and hormone-associated effects of pregnancy inducing a differential growth of four murine tumors.
Bustuoabad OD; di Gianni PD; Franco M; Kordon EC; Vanzulli SI; Meiss RP; Grion LC; Díaz GS; Nosetto SH; Hockl P; Lombardi MG; Pasqualini CD; Ruggiero RA
Oncol Res; 2002; 13(3):147-60. PubMed ID: 12549624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
